Versant Venture Capital VI, L.P.'s Form 4 filing
Monte Rosa Therapeutics, Inc. (GLUE) · filed Oct 30, 2024
- Accession no.
- 0000950170-24-119051
- Filed
- Oct 30, 2024, 4:35 PM ET
- Trade date
- Oct 28-29, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 13 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.49M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Versant Venture Capital VI, L.P.CIK 0001687880 | 10% Owner |
| Versant Vantage I, L.P.CIK 0001765253 | 10% Owner |
| Versant Vantage I GP, L.P.CIK 0001777651 | 10% Owner |
| Versant Ventures VI GP-GP, LLCCIK 0001777652 | 10% Owner |
| Versant Vantage I GP-GP, LLCCIK 0001777653 | 10% Owner |
| Versant Ventures VI GP, L.P.CIK 0001777654 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | Common Stock | SSaleDisposed | −89,990 | $9.66 | −$869,240.41 | 2,007,948 | Indirect | |
| Oct 28, 2024 | Common Stock | JOtherDisposed | −1,019,867 | $0.00 | $0 | 4,079,469 | Direct | |
| Oct 28, 2024 | Common Stock | JOtherAcquired | +20,397 | $0.00 | $0 | 20,397 | Indirect | |
| Oct 28, 2024 | Common Stock | JOtherDisposed | −20,397 | $0.00 | $0 | 0 | Indirect | |
| Oct 28, 2024 | Common Stock | JOtherAcquired | +17,595 | $0.00 | $0 | 17,595 | Indirect | |
| Oct 28, 2024 | Common Stock | JOtherDisposed | −17,595 | $0.00 | $0 | 0 | Indirect | |
| Oct 28, 2024 | Common Stock | JOtherDisposed | −366,590 | $0.00 | $0 | 1,641,358 | Indirect | |
| Oct 28, 2024 | Common Stock | JOtherAcquired | +5,499 | $0.00 | $0 | 5,499 | Indirect | |
| Oct 28, 2024 | Common Stock | JOtherDisposed | −5,499 | $0.00 | $0 | 0 | Indirect | |
| Oct 28, 2024 | Common Stock | JOtherAcquired | +5,454 | $0.00 | $0 | 5,454 | Indirect | |
| Oct 28, 2024 | Common Stock | JOtherDisposed | −5,454 | $0.00 | $0 | 0 | Indirect | |
| Oct 29, 2024 | Common Stock | SSaleDisposed | −52,305 | $9.08 | −$475,007.86 | 1,589,053 | Indirect | |
| Oct 29, 2024 | Common Stock | SSaleDisposed | −15,600 | $9.41 | −$146,792.88 | 1,573,453 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.